Comment: JAVELIN-100 for metastatic urothelial cancer

Bookmark and Share
Published: 12 Jun 2020
Views: 483
Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA

Dr Elizabeth Plimack talks to ecancer in an online interview for the ASCO virtual meeting 2020 and makes a comment on the JAVELIN-100 trial.

She initially outlines the reasoning for the trial design.

Dr Plimack explains what her opinion was from the outcome of this study, and whether patients should undergo maintenance or a treatment break.